Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

NCT02570035 · clinicaltrials.gov ↗

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder
Cardiovascular Disease

Interventions

DRUG: Mirabegron

Sponsor

Astellas Pharma Inc